Anixa Biosciences Inc 10-K filing
Filed 2026-01-12 · Report date 2025-10-31 · 2025 FY
Filing metadata
- Accession number
- 0001493152-26-001845
- Form type
- 10-K
- CIK
- 0000715446
- Primary document
- https://www.sec.gov/Archives/edgar/data/715446/000149315226001845/form10-k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Anixa Biosciences Inc.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-11.7M | - | - |
| Net Income | $-10.9M | - | - |
| Eps Basic | -0.34 | - | - |
| Eps Diluted | -0.34 | - | - |
| Cash And Equivalents | $1.2M | - | - |
| Total Assets | $16.1M | - | - |
| Total Liabilities | $2.1M | - | - |
| Shareholders Equity | $15.2M | - | - |
| Operating Cash Flow | $-7.2M | - | - |